News
Honourable mentions for BarentsKrans in the Legal 500
This week Legal 500 released their 2018 rankings. As in previous years, BarentsKrans is mentioned several times in this leading, international guide for the legal profession. Again we are beyond proud of these honourable mentions. High performers BarentsKrans is mentioned at nine different practice areas. Employment, Corporate/M&A, EU & Competition, Private equity, Real estate, Commercial Litigation,
Read more ›
Rollercoaster manufacturer Vekoma Rides acquired by Sansei Technologies
Dutch roller coaster manufacturer Vekoma Rides, one of the biggest suppliers to amusement parks worldwide, has been acquired in full by the Japanese Sansei Technologies. With the acquisition of 100% of the shares, Sansei will increase its global market share in the field of designing, supplying and installing roller coasters. The collaboration with Sansei is
Read more ›
Pharma update: tadalafil patent invalidated
The District Court of The Hague has invalidated ICOS’ patent EP 1 173 181 B3 (‘EP ‘181’) claiming a dosage range of tadalafil for the treatment of sexual dysfunction. Icos Corporation (‘Icos’), an Eli Lilly and Company subsidiary, distributes the medicinal product Cialis® containing tadalafil for the treatment of sexual dysfunction in adult men. EP
Read more ›
Chambers Europe 2018 rankings: again splendid results for BarentsKrans
Last month we published the stunning results that BarentsKrans achieved in the Chambers 2018 Global edition. Meanwhile, the Chambers Europe guide has also been published and we would, once again, like to share our Chambers feedback with you. Chambers and Partners publish their rankings annually while comparing 53 jurisdictions across Europe, from Greenland and the United Kingdom to
Read more ›
Chambers Global 2018 rankings: excellent results for BarentsKrans
Chambers Global 2018, the guide that provides a worldwide overview of international practice areas, has just been released. BarentsKrans received several honourable mentions. This year the most noticeable mention is the Corporate / M&A practice group’s first ranking within the Mid-Markets category. Like last year, the Intellectual Property team has been rewarded with a splendid
Read more ›
Marleen van den Horst receives Client Choice award
Each year, Client Choice recognises those law firm partners around the world that stand apart for the excellent client service they provide. Uniquely, these awards survey senior corporate counsel only, with this year’s winners chosen from a pool of more than 2,000 individual client assessments. On February 8 the award for Healthcare & Life Sciences
Read more ›
Lawsuit on behalf of Steinhoff shareholders
BarentsKrans, specialised in mass litigation, is commencing legal proceedings on behalf of aggrieved shareholders of Steinhoff International Holdings N.V. with the claim to include accountants Deloitte as co-defendants. The claim will be conducted in the Netherlands with Steinhoff shareholders from all over the world eligible to participate. It follows announcements by Steinhoff in December
Read more ›
Administrative law specialist Remco Bäcker joins BarentsKrans
Administrative law specialist Remco Bäcker (b. 1976) joined BarentsKrans as a partner on 1 January 2018. Remco was previously a partner at Loyens & Loeff where he was in charge of the administrative law division. Joining him in the move from Loyens & Loeff is Nicole Soliana, specialist in public sector private law. Remco specialises
Read more ›
Success in Bank Indonesia / trustees Indover Bank
Following the demise of its Dutch subsidiary Indover Bank in the credit crisis of 2008, Bank Indonesia (the Indonesian Central Bank) was sued by the bankruptcy trustees in the Netherlands. They asserted that in 1998 Bank Indonesia had issued a guarantee to Indover Bank to maintain its solvency as long as it would remain its
Read more ›
Pharma update: Indirect infringement of Swiss type claims is possible
In its judgment of 3 November 2017 in the case between Merck Sharp & Dohme (‘MSD’) and Teva, the Dutch Supreme Court ruled (ECLI:NL:HR:2017:2807) that indirect infringement of a ‘Swiss type’ second medical use patent claim is possible. In addition, the Supreme Court found that there is no difference in the scope of protection of second
Read more ›
